×
ADVERTISEMENT

CABOSUN

Cabozantinib Improves PFS in Advanced RCC

Cabozantinib can improve PFS in patients with previously untreated advanced or metastatic RCC, according to updated ...

SEPTEMBER 21, 2017

Cabozantinib Beats Sunitinib In Metastatic RCC Study

In first-line treatment of poor- or intermediate-risk mRCC, cabozantinib results in a substantially longer ...

NOVEMBER 8, 2016

Load more